Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  6. Financials
    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

(600196)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 57 94865 086125 791198 079--
Entreprise Value (EV)1 72 60477 050139 217213 996216 555216 385
P/E ratio 21,7x20,5x37,8x48,5x38,3x30,3x
Yield 1,38%1,47%0,80%0,63%0,83%1,09%
Capitalization / Revenue 2,34x2,28x4,15x4,93x4,30x4,00x
EV / Revenue 2,94x2,70x4,59x5,33x4,71x4,36x
EV / EBITDA 21,1x13,1x22,2x30,8x26,4x21,8x
Price to Book 2,13x2,14x3,74x5,33x4,84x4,37x
Nbr of stocks (in thousands) 2 563 0612 562 8992 562 8992 562 899--
Reference price (CNY) 23,326,654,082,482,482,4
Announcement Date 03/25/201903/30/202003/29/2021---
1 CNY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 24 71428 58530 30740 18446 02249 578
EBITDA1 3 4375 8746 2826 9468 1879 911
Operating profit (EBIT)1 2 0914 4944 7214 7445 8147 193
Operating Margin 8,46%15,7%15,6%11,8%12,6%14,5%
Pre-Tax Profit (EBT)1 3 5804 5264 6785 7567 3959 084
Net income1 2 7083 3223 6634 3725 6106 888
Net margin 11,0%11,6%12,1%10,9%12,2%13,9%
EPS2 1,071,301,431,702,152,72
Dividend per Share2 0,320,390,430,520,690,90
Announcement Date 03/25/201903/30/202003/29/2021---
1 CNY in Million
2 CNY
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q2 2020 Q3 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 8 0858 0758 05630 0909 26911 223
EBITDA ------
Operating profit (EBIT)1 --1 1591 0515371 330
Operating Margin --14,4%3,49%5,79%11,9%
Pre-Tax Profit (EBT) ------
Net income ------
Net margin ------
EPS2 0,440,300,330,950,380,48
Dividend per Share ------
Announcement Date 08/25/202010/29/202004/26/2021---
1 CNY in Million
2 CNY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 14 65711 96413 42615 91718 47618 306
Net Cash position1 ------
Leverage (Debt / EBITDA) 4,26x2,04x2,14x2,29x2,26x1,85x
Free Cash Flow1 -367-706-1 8571 8753 2734 136
ROE (Net Profit / Equities) 10,2%11,6%10,8%11,0%12,8%14,0%
Shareholders' equity1 26 59528 75933 79039 75143 84649 380
ROA (Net Profit / Asset) 4,09%4,53%4,58%5,50%6,20%6,90%
Assets1 66 25773 34179 90479 48390 48699 833
Book Value Per Share2 10,912,414,415,517,018,9
Cash Flow per Share2 1,151,261,011,691,851,96
Capex1 3 3173 9284 4371 6561 6661 676
Capex / Sales 13,4%13,7%14,6%4,12%3,62%3,38%
Announcement Date 03/25/201903/30/202003/29/2021---
1 CNY in Million
2 CNY
Key data
Capitalization (CNY) 198 078 944 436
Capitalization (USD) 30 653 359 606
Net sales (CNY) 30 306 981 260
Net sales (USD) 4 690 823 638
Number of employees 32 258
Sales / Employee (CNY) 939 518
Sales / Employee (USD) 145 416
Free-Float 58,8%
Free-Float capitalization (CNY) 116 464 540 528
Free-Float capitalization (USD) 18 023 265 685
Avg. Exchange 20 sessions (CNY) 5 163 366 552
Avg. Exchange 20 sessions (USD) 799 170 385
Average Daily Capital Traded 2,6%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA